Non-ossifying fibromas (NOFs) are benign bone tumors that can affect bone development in children and adolescents. They are the most common type of bone tumor in this age group, accounting for up to 15% of all bone tumors. NOFs are usually asymptomatic, but they can cause pain and deformity if they grow in close proximity to a joint or if they compress a nerve. The exact cause of NOFs is not known, but they are believed to be related to abnormal bone growth. In this article, we will explore the impact of NOFs on bone development and how they can be managed.
NOFs are benign tumors of the bone that typically occur in the long bones of the arms and legs, but can also occur in other bones such as the ribs, pelvis, and spine. They are most common in children and adolescents, especially those between the ages of 5 and 15. NOFs are made up of spindle-shaped cells that are surrounded by a fibrous capsule. They are often referred to as �fibrous cortical defects� because they form in the outer layer of the bone (the cortex).
The exact cause of NOFs is not known, but it is believed to be related to abnormal bone growth. It is thought that the tumor cells form as a result of an imbalance between bone formation and bone resorption. This imbalance can be caused by genetic factors, environmental factors, or a combination of both.
NOFs are usually asymptomatic, but they can cause pain and deformity if they grow in close proximity to a joint or if they compress a nerve. Symptoms may include pain, swelling, and tenderness in the affected area. In some cases, the tumor may be visible on X-rays.
The diagnosis of NOFs is usually made based on the patient�s symptoms and imaging studies such as X-rays or CT scans. A biopsy may also be performed to confirm the diagnosis.
NOFs are usually treated with observation and monitoring, as most tumors will not grow or cause any symptoms. Surgery may be necessary if the tumor is causing pain or deformity, or if it is growing rapidly. Surgery is usually done to remove the tumor and any affected bone. In some cases, radiation therapy may also be used.
NOFs can affect bone development in children and adolescents. The tumors can cause deformity and pain, and they can interfere with the normal growth of the bone. In some cases, the tumor can cause the bone to become thicker or weaker, which can lead to long-term problems with the development of the bone.
Non-ossifying fibromas (NOFs) are the most common type of bone tumor in children and adolescents. They are usually asymptomatic, but can cause pain and deformity if they grow in close proximity to a joint or if they compress a nerve. The exact cause of NOFs is not known, but it is believed to be related to abnormal bone growth. NOFs can affect bone development in children and adolescents, and can cause deformity and pain. Treatment usually involves observation and monitoring, but surgery may be necessary if the tumor is causing pain or deformity, or if it is growing rapidly.
1.
How access to specialized cancer centers affects glioblastoma outcomes
2.
Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists
3.
Positive Trials; Malignancies Increasing in Younger Adults; Andre Braugher's Cancer Dx.
4.
U.S. Nurse Found Dead; Harvey Weinstein's Cancer; Creepy Source of Ear Pain
5.
Beyond What Is Visible in Myelofibrosis?
1.
Beyond the Biopsy: Decoding Tumor Biology Through the Lens of Radiogenomics
2.
The Millionaire's Battle: Does Mark Cuban Have Cancer?
3.
Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights
4.
Understanding Adenomyosis: The Role of Ultrasound in Diagnosis Introduction
5.
Octreotide's Efficacy in Reducing Transfusion Requirements in Angiodysplasia Bleeding
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Advances in Modern Cancer Treatment
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
3.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
5.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation